Related Experiment Video
Updated: Sep 29, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Parental COVID-19 vaccine hesitancy for children with neurodevelopmental disorders: a cross-sectional survey
Mohammad Ali1,2, Tasnuva Shamarukh Proma3, Zarin Tasnim4
1Department of Physiotherapy and Rehabilitation, Uttara Adhunik Medical College and Hospital, Uttara Model Town, Dhaka, 1230, Bangladesh. m180002@student.bup.edu.bd.
Insights
Over 42% of parents in Bangladesh hesitated to vaccinate children with neurodevelopmental disorders against COVID-19. Key factors included living in the northern zone and perceived lack of vaccine safety or personal risk.
Area of Science:
- Public Health
- Epidemiology
- Pediatrics
Background:
- Parental hesitancy towards COVID-19 vaccination for children with neurodevelopmental disorders (NDD) is understudied.
- This study aimed to determine the prevalence and predictors of vaccine hesitancy in this population.
Purpose of the Study:
- To estimate the prevalence of COVID-19 vaccine hesitancy among parents of children with NDD in Bangladesh.
- To identify factors associated with this hesitancy to inform targeted interventions.
Main Methods:
- A cross-sectional survey was conducted with 396 parents of children with NDD in Bangladesh.
- Data were collected via a structured vaccine hesitancy questionnaire and face-to-face interviews.
- Multiple logistic regression analysis identified predictors of vaccine hesitancy.
Main Results:
- Nearly half (42.7%) of parents surveyed expressed hesitancy towards vaccinating their children against COVID-19.
- Significant predictors of hesitancy included parental residence in the northern zone, belief in vaccine ineffectiveness, unvaccinated parental status, and lower perceived personal or family risk of COVID-19 infection.
- Lack of concern about future COVID-19 infection also correlated with increased hesitancy.
Conclusions:
- High COVID-19 vaccine hesitancy among parents of children with NDD necessitates targeted public health strategies.
- Interventions should address parental concerns about vaccine safety, efficacy, and personal risk perception.
- Ensuring vaccination for children with NDD, their caregivers, and families is crucial for mitigating pandemic-related risks.
Background:
Little is known about parental coronavirus disease 2019 (COVID-19) vaccine hesitancy in children with neurodevelopmental disorders (NDD). This survey estimated the prevalence and predictive factors of vaccine hesitancy among parents of children with NDD.
Methods:
A nationally representative cross-sectional survey was conducted from October 10 to 31, 2021. A structured vaccine hesitancy questionnaire was used to collect data from parents aged ≥ 18 years with children with NDD. In addition, individual face-to-face interviews were conducted at randomly selected places throughout Bangladesh. Multiple logistic regression analysis was conducted to identify the predictors of vaccine hesitancy.
Results:
A total of 396 parents participated in the study. Of these, 169 (42.7%) parents were hesitant to vaccinate their children. Higher odds of vaccine hesitancy were found among parents who lived in the northern zone (AOR = 17.15, 95% CI = 5.86-50.09; p < 0.001), those who thought vaccines would not be safe and effective for Bangladeshi children (AOR = 3.22, 95% CI = 1.68-15.19; p < 0.001), those who were either not vaccinated or did not receive the COVID-19 vaccine themselves (AOR = 12.14, 95% CI = 8.48-17.36; p < 0.001), those who said that they or their family members had not tested positive for COVID-19 (AOR = 2.13, 95% CI = 1.07-4.25), and those who did not lose a family member to COVID-19 (AOR = 2.12, 95% CI = 1.03-4.61; p = 0.040). Furthermore, parents who were not likely to believe that their children or a family member could be infected with COVID-19 the following year (AOR = 4.99, 95% CI = 1.81-13.77; p < 0.001) and who were not concerned at all about their children or a family member being infected the following year (AOR = 2.34, 95% CI = 1.65-8.37; p = 0.043) had significantly higher odds of COVID-19 vaccine hesitancy.
Conclusions:
Given the high prevalence of vaccine hesitancy, policymakers, public health practitioners, and pediatricians can implement and support strategies to ensure that children with NDD and their caregivers and family members receive the COVID-19 vaccine to fight pandemic induced hazards.
Related Concept Videos
Vaccinations
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Learning Disabilities
Dyslexia
Dyslexia is a...
Oppositional Defiant Disorder
Diagnostic Criteria and...

